Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| SBI Innovative Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | SBI | HDFC |
| NAV | ₹11.1772 | ₹23.6750 |
| NAV date | 19 Nov 2026 | 20 Nov 2026 |
| History | 2.2 years | 3.1 years |
| Expense ratio | 1.0% | 1.1% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 94.50 |
Returns
| SBI Innovative Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +6.15% | +12.97% |
| 3 months | +3.21% | +7.13% |
| 6 months | +21.18% | +17.84% |
| YTD | +11.10% | +33.73% |
| 1 year | +11.49% | +32.20% |
| 3 years (CAGR) | — | +30.70% |
| 5 years (CAGR) | — | — |
| 10 years (CAGR) | — | — |
| Since launch | +4.82% | +31.83% |
Risk
| SBI Innovative Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | — | 15.8% |
| Downside volatility | — | 8.5% |
| Sharpe | — | 1.53 |
| Sortino | — | 2.86 |
| Calmar | — | 2.06 |
| Return / risk | — | 1.95 |
| Deepest fall | −20.79% | −14.91% |
| Days to recover | 478 | 126 |
| Below its high | −1.83% | +0.00% |
Against benchmark
| SBI Innovative Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | — | +7.54% |
| Beta | — | 0.97 |
| R² | — | 85.0% |
| Up capture | — | 108.9% |
| Down capture | — | 71.0% |
| Tracking error | — | 6.1% |
| Information ratio | — | 1.17 |
| Treynor | — | 0.24 |
Consistency
| SBI Innovative Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +14.60% | +67.01% |
| Middle 1-year | +2.30% | +23.25% |
| Worst 1-year | −7.08% | +1.71% |
| 1-year periods with a loss | 38.0% | 0.0% |
| Middle 3-year | — | +30.22% |
| Positive months | — | 72.2% |
| Best day | +3.45% | +3.18% |
| Worst day | −3.37% | −3.61% |
| Worst 5% day | −1.63% | −1.51% |
| Positive days | 52.1% | 58.3% |
| NAVs a year | 252 | 247 |
SIP of ₹10,000 a month
| SBI Innovative Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | — | — |
| 5-year value | — | — |
| 3-year XIRR | — | +27.71% |
| 1-year XIRR | +26.22% | +41.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.